Irisity AB (”Irisity” or ”the Company”) published its Q3 report for 2026 on November 17th, 2026. The following are key events that we have chosen to highlight in the report:
- Net Sales of SEK 20.3m (24.6), -18% Y-Y – Below Estimate as Two Larger Deals Were Pushed Into Q4, Against a Tough One-Off Comparable
- MRR of SEK 4.7m (4.0), +16% Y-Y – Recurring Revenue Accounts for ~70% of Net Sales in Q3-26
- Solid Deal Activity – Multi-Year Renewals and Expansions with U.S. Government and Transit Customers, Three New Smart Cities in Romania
- Invoicing of SEK 20.4m (34.9), -41% Y-Y; Collections of SEK 22.1m (19.9), +11% Y-Y
- Gross Margin of 77.7% (81.5) – Temporarily Weighed Down by a Hardware-Heavy Mix
- OPEX of SEK 20.8m (30.0), -31% Y-Y – 30% Reduction Target Surpassed, Partly Helped by Accrual Releases
- EBITDA of SEK -5.1m (-10.0) – Improved Y-Y, but Below Estimate of SEK -2.3m
- Available Liquidity of SEK 4.4m (5.5) – Stockhorn Facility Raised to SEK 15m
Deal Slippage and a Tough Comparable Weigh on Net Sales, While the Recurring Base Holds Firm
Net sales for Q3-26 amounted to SEK 20.3m (24.6), a decrease of 18% Y-Y and 26% sequentially, and approx. 21% below Analyst Group’s estimate of SEK 25.7m. While a softer quarter was anticipated against a strong Q3-25, the deviation from our estimate is partly attributable to two larger deals that were postponed from Q3 into Q4. On a YTD basis, net sales amounted to SEK 66.8m (60.7), corresponding to growth of 10% Y-Y.
The Y-Y decline should be assessed in light of the revenue composition. Q3-25 benefited from unusually high one-off revenue, driven by several contract wins, including an expansion with a U.S. federal government agency, a major transportation project in New York City and a competitive project takeover for a C5i 911 center in Mexico. A similar dynamic was evident in Q2-26, when project-related sales were the main contributor to net sales growth of 52% Y-Y. Hence, swings in one-off revenue account for most of the volatility in reported growth, a dynamic examined further in the MRR section below.
MRR Rises 16% Y-Y, Confirming That the Sales Decline Stems From One-Off Revenue
MRR amounted to SEK 4.7m (4.0) in Q3-26, an increase of 16% Y-Y and approx. 4% sequentially from SEK 4.5m in Q2-26, equivalent to an ARR of approx. SEK 56m, or approx. 66% of LTM net sales. The Company did not disclose an FX-adjusted MRR for the quarter. However, with the average USD/SEK rate in Q3-26 broadly in line with Q3-25 (+1.5% Y-Y), Analyst Group assesses the Y-Y increase as largely organic, while the sequential uptick was partly supported by a somewhat stronger USD versus Q2-26 (+3.1% Q-Q). According to management, the development was held back by the two larger deals pushed into Q4. This implies that the delayed deals carry recurring components, and provided they are closed as expected, Analyst Group expects them to support MRR growth in Q4-26.
The continued MRR growth also helps explain the Y-Y decline in net sales. The chart below approximates this dynamic, splitting reported net sales into a recurring component, proxied as MRR x 3, and the derived one-off revenue. The split is a simplification, as recognized recurring revenue need not equal MRR x 3 exactly, but it captures the underlying dynamic well enough to be instructive.

The split makes the character of the quarter clear. While the recurring component continued its gradual climb, the derived one-off revenue more than halved Y-Y, from approx. SEK 13m to approx. SEK 6m, against the strong project-driven Q3-25. As a result, recurring revenue accounted for approx. 70% of net sales in Q3-26, a share lifted by the low one-off contribution, but which nevertheless shows that the revenue base is becoming increasingly predictable. Analyst Group therefore assesses the weaker top line as driven by timing and comparison effects. That said, the deal slippage shows that quarterly sales remain sensitive to the timing of individual larger orders.
Commercial Activity Validates Customer Stickiness and the Partner-First Model
The commercial activity in the quarter supports the recurring revenue development, with several wins consisting of renewals and expansions within existing accounts. In the U.S., a longstanding transit customer in the Northeast extended support for 490 existing AI Guarding licenses and added 150 new licenses, bringing the total deployment to more than 1,000 channels. Furthermore, a U.S. federal agency signed a five-year support extension covering 1,200 channels, securing software support through 2031, while a separate U.S. government agency placed its ninth order in four years on a sole-source basis, with a tenth order currently being processed. In Europe, three new Romanian cities deployed IRIS+ through two local partners. Analyst Group views the multi-year renewals among U.S. government customers as particularly valuable, as they validate the stickiness of the AI Solutions segment and lock in high-margin recurring revenue, while the Romanian deployments demonstrate the partner-first model in practice.
Invoicing Normalizes as Q3-25 Project Wins Fall Out, While Collections Continue to Outpace Billing
Invoicing amounted to SEK 20.4m (34.9), down 41% Y-Y and 29% sequentially, reflecting the lower one-off revenue and the strong Q3-25 comparable driven by the large project wins. On an LTM basis, invoicing declined to approx. SEK 100m, from approx. SEK 114m after Q2-26, but still runs at approx. 1.2x LTM net sales of approx. SEK 85m. As a meaningful share of invoiced amounts, notably recurring SUP and SaaS, is recognized as revenue over the duration of the underlying contracts, this points to a layer of contracted volume not yet reflected in the top line, also visible in deferred income of approx. SEK 24m on the balance sheet at quarter-end.
Collections amounted to SEK 22.1m (19.9), up 11% Y-Y, though down 33% sequentially from a strong Q2-26. Notably, collections exceeded invoicing for the second consecutive quarter, and year-to-date collections of SEK 77.1m (66.2) compare with invoicing of SEK 71.4m (72.7), a tangible result of the improved quote-to-cash cycle under the partner-first model and the shift to monthly invoicing. That said, with the lower invoicing in Q3-26, Analyst Group expects the support from collections to ease in Q4, unless the delayed deals are invoiced early in the quarter.
Cost Target Surpassed, but a Weaker Top Line and Hardware Mix Push Adj. EBITDA Below Estimate
The gross margin came in at 77.7% (81.5), below Analyst Group’s estimate of 86.1% and the 86.3% reached in Q2-26, due to increased hardware deliveries during the quarter. Analyst Group views the margin dip as mix-driven and temporary rather than structural, given that recurring software revenue carries a gross margin close to 100%.
OPEX (excl. COGS and D&A) amounted to SEK 20.8m (30.0), a decrease of 31% Y-Y and 18% sequentially, and approx. 15% below Analyst Group’s estimate of SEK 24.4m. Irisity has thereby surpassed its 30% cost reduction target, which was still not fully reached in Q2-26. Personnel costs declined 31% Y-Y to SEK 15.4m (22.3), while other external charges fell 30% Y-Y to SEK 5.4m (7.7). However, the quarter was positively impacted by the release of vacation pay accruals and lower commission accruals as sales shifted into Q4.
The underlying cost discipline is evident across the cost base. FTEs have decreased by approx. 27% Y-Y to 53 (73), while other external charges, unaffected by the accrual effects, fell 30% Y-Y. As the headcount was unchanged Q-Q, Analyst Group assesses that the sequential decline in personnel costs was largely accrual-driven, implying an underlying run rate somewhat above the reported SEK 20.8m. OPEX is also expected to increase in Q4-26 as deferred commissions follow the delayed deals. Overall, Analyst Group considers the cost base structurally reset, providing a solid foundation for operating leverage as sales growth resumes.

Adjusted EBITDA, excluding work performed for own account, other operating income and costs, amounted to SEK -5.1m (-10.0), an improvement of approx. SEK 4.9m Y-Y, but approx. SEK 2.7m below Analyst Group’s estimate of SEK -2.3m. The deviation is primarily explained by lower-than-expected sales, which, together with the lower gross margin, could only partly be offset by the lower OPEX. As the cost base is largely fixed, a revenue shortfall has a direct impact on earnings, illustrating the operating leverage in the business model, in both directions. On a reported basis, EBITDA amounted to SEK -1.7m (-7.5), supported by work performed for own account of SEK 2.7m (5.3) and other operating income of SEK 2.1m (1.6).

Management reiterated its ambition of full-year EBITDA break-even, which, given a YTD reported EBITDA of SEK -5.1m, requires a reported EBITDA of approx. SEK 5m in Q4-26. Analyst Group considers the target ambitious. Assuming a contribution from capitalized work and other operating items in line with Q3-26, and an OPEX base largely in line with Q3-26 but with slightly higher personnel costs, the target would require net sales of approx. SEK 30m in Q4-26. This implies growth of approx. 60% Y-Y, leaving limited room for further deal slippage, as reaching this level is likely to require several larger deals to close within the quarter.
Liquidity Remains the Key Area to Monitor as Reliance on the Main Owner Increases
Cash flow from operating activities before changes in working capital improved to SEK -1.8m (-7.9), while cash flow from operating activities amounted to SEK -4.9m (-18.4), burdened by working capital of approx. SEK -3.1m. Including investing activities of SEK -3.3m (-5.0), free cash flow amounted to approx. SEK -8.3m, a substantial improvement from approx. SEK -23.5m in Q3-25, but weaker than the approx. SEK -2.9m in Q2-26. The negative free cash flow was funded through financing activities of SEK 6.4m, mainly drawdowns under the credit facility with the largest shareholder, Stockhorn Capital AB.
During the quarter, the Stockhorn facility was raised from SEK 5m to SEK 15m in two steps, of which SEK 12m was drawn at quarter-end, bringing the total loan from Stockhorn, including earlier loans, to SEK 20.1m. Cash and available credit lines amounted to SEK 4.4m (5.5), down from SEK 5.6m at the end of Q2-26, while SEK 3m remained undrawn under the Stockhorn facility. Net debt amounted to SEK 35.7m (37.4), up from SEK 27.5m at the end of Q2-26.
Analyst Group continues to view liquidity as the principal area to monitor. The repeated facility increases demonstrate continued support from the main owner, which reduces the near-term financing risk. Moreover, working capital has historically tended to develop favorably in Q4, which, together with the delayed deals, could support cash flow in the coming quarter. However, the buffer remains thin, and Analyst Group cannot rule out that further bridge measures or external capital may be required before durable cash flow neutrality is reached, making the timing of the delayed deals and associated collections important in the coming quarters.
Concluding Remarks About the Report
In summary, Analyst Group views Q3-26 as a softer quarter, in line with the anticipated direction but weaker than expected in magnitude. Net sales of SEK 20.3m declined 18% Y-Y and came in approx. 21% below our estimate (SEK 25.7m), as two larger deals were postponed into Q4. The decline is entirely attributable to one-off revenue, which more than halved Y-Y against a strong comparable, while the recurring base continued to grow, with MRR up 16% Y-Y to SEK 4.7m. Analyst Group therefore assesses the weaker top line as a matter of timing rather than a sign of weakening underlying demand. OPEX decreased 31% Y-Y to SEK 20.8m, surpassing the 30% reduction target, although partly helped by accrual effects, while the lower sales and a hardware-driven dip in the gross margin resulted in an adj. EBITDA of SEK -5.1m, below our estimate of SEK -2.3m. Liquidity remains the principal risk, with net debt rising to SEK 35.7m and an increasing reliance on the main owner. Looking ahead, the soft comparable in Q4-26, the delayed deals and the higher recurring base create good conditions for a strong coming quarter. Overall, Analyst Group considers the long-term investment thesis intact, with the near-term focus now on converting the delayed deals into sales and cash flow.
We will return with an updated equity research report of Irisity.
